MCID: PRS076
MIFTS: 14

Prostate Cancer, Hereditary, 15

Categories: Cancer diseases, Genetic diseases, Rare diseases, Reproductive diseases

Aliases & Classifications for Prostate Cancer, Hereditary, 15

MalaCards integrated aliases for Prostate Cancer, Hereditary, 15:

Name: Prostate Cancer, Hereditary, 15 54 13

Classifications:



External Ids:

OMIM 54 611959

Summaries for Prostate Cancer, Hereditary, 15

MalaCards based summary : Prostate Cancer, Hereditary, 15 An important gene associated with Prostate Cancer, Hereditary, 15 is HPC15 (Prostate Cancer, Hereditary, 15). The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include prostate and breast.

Description from OMIM: 611959

Related Diseases for Prostate Cancer, Hereditary, 15

Symptoms & Phenotypes for Prostate Cancer, Hereditary, 15

Clinical features from OMIM:

611959

Drugs & Therapeutics for Prostate Cancer, Hereditary, 15

Drugs for Prostate Cancer, Hereditary, 15 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 1 159351-69-6 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 1 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 1 53123-88-9 5284616 6436030 46835353
4
Vinblastine Approved Phase 1 865-21-4 13342 241903
5
Vinorelbine Approved, Investigational Phase 1 71486-22-1 60780 44424639
6 Anti-Bacterial Agents Phase 1
7 Antibiotics, Antitubercular Phase 1
8 Antifungal Agents Phase 1
9 Anti-Infective Agents Phase 1
10 Antimitotic Agents Phase 1
11 Antineoplastic Agents, Phytogenic Phase 1
12 Immunosuppressive Agents Phase 1

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer Recruiting NCT02203513 Phase 2 LY2606368
2 Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors Completed NCT01155258 Phase 1 temsirolimus;vinorelbine ditartrate
3 Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer Recruiting NCT00050752

Search NIH Clinical Center for Prostate Cancer, Hereditary, 15

Genetic Tests for Prostate Cancer, Hereditary, 15

Anatomical Context for Prostate Cancer, Hereditary, 15

MalaCards organs/tissues related to Prostate Cancer, Hereditary, 15:

39
Prostate, Breast

Publications for Prostate Cancer, Hereditary, 15

Variations for Prostate Cancer, Hereditary, 15

Expression for Prostate Cancer, Hereditary, 15

Search GEO for disease gene expression data for Prostate Cancer, Hereditary, 15.

Pathways for Prostate Cancer, Hereditary, 15

GO Terms for Prostate Cancer, Hereditary, 15

Sources for Prostate Cancer, Hereditary, 15

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....